Transcytosis Pathways
Transcytosis pathways are the vesicle-mediated routes that let drugs cross the blood-brain barrier by traveling through endothelial cells, rather than slipping between them. This active transport is vital for delivering large molecules to the brain in pharmaceutical development.
Transcytosis pathways are specialized biological mechanisms enabling vesicle-mediated transport of molecules across endothelial cells, particularly in the blood-brain barrier. This active process involves endocytosis, intracellular trafficking, and exocytosis, allowing large or hydrophobic compounds to traverse dense cellular barriers without disrupting tight junctions. It is distinct from passive diffusion and is critical for pharmaceutical drug delivery to the central nervous system.
What this means in real life
When you eat a protein-rich meal, large protein molecules cannot simply pass through intestinal cell walls. Instead, intestinal cells wrap them in tiny membrane packets, shuttle them across the cell, and release them into the bloodstream—a process that lets nutrients enter your body while keeping harmful substances out.
What it isn’t
Not simple diffusion or passive leakage through cell membranes. Transcytosis is an active, energy-dependent process requiring cellular machinery; it is not the same as molecules freely dissolving through the lipid bilayer.
Commonly misused online
Often conflated with 'endocytosis' or 'exocytosis' alone, when transcytosis specifically means the complete journey across the cell—endocytosis on entry, transport, and exocytosis on exit as one coordinated pathway.